- Home
- TCRX vs PXLW Comparison
TCRX vs PXLW Comparison
Compare TCRX & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | PXLW |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 41.3M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TCRX | PXLW |
|---|---|---|
| Price | $0.24 | $6.05 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 761.4K | 22.6K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ 12.07 |
| Revenue | ★ $10,325,000.00 | $693,000.00 |
| Revenue This Year | N/A | $58.73 |
| Revenue Next Year | N/A | $63.64 |
| P/E Ratio | ★ N/A | $0.50 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.22 | $4.84 |
| 52 Week High | $2.57 | $15.36 |
Technical Indicators
Market Signals| Indicator | TCRX | PXLW |
|---|---|---|
| Relative Strength Index (RSI) | 24.14 | 37.90 |
| Support Level | N/A | $5.64 |
| Resistance Level | $0.37 | $6.46 |
| Average True Range (ATR) | 0.03 | 0.28 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 12.62 | 14.25 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.